Mangoceuticals Files Definitive Proxy Statement
Ticker: MGRX · Form: DEF 14A · Filed: Feb 18, 2025 · CIK: 1938046
| Field | Detail |
|---|---|
| Company | Mangoceuticals, INC. (MGRX) |
| Form Type | DEF 14A |
| Filed Date | Feb 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance
TL;DR
Mangoceuticals DEF 14A filed. Get ready to vote.
AI Summary
Mangoceuticals, Inc. filed its definitive proxy statement on February 18, 2025, for its annual meeting. The company, located at 15110 Dallas Pkwy, Suite 600, Dallas, TX 75248, is seeking shareholder approval for matters related to its corporate governance and operations. The filing indicates no fee was required for this submission.
Why It Matters
This filing provides shareholders with crucial information regarding upcoming votes and company proposals, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine filing for a public company's proxy statement and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- Mangoceuticals, Inc. (company) — Registrant
- 15110 Dallas Pkwy, Suite 600, Dallas, Texas 75248 (location) — Company Address
- February 18, 2025 (date) — Filing Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by a company to provide shareholders with information they need to vote on matters at an upcoming shareholder meeting.
Who is the filer of this document?
The filer is Mangoceuticals, Inc.
What is the filing date of this document?
The filing date is February 18, 2025.
What is the business address of Mangoceuticals, Inc.?
The business address is 15110 Dallas Pkwy, Suite 600, Dallas, Texas 75248.
Was a fee required for this filing?
No fee was required for this filing, as indicated by the 'No fee required' checkbox being selected.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on February 18, 2025 regarding MANGOCEUTICALS, INC. (MGRX).